IMARC Group은 2024년 바이오프리저베이션 시장 세계 시장 규모가 85억 달러에 달했으며, 2025-2033년간 9.98%의 연평균 성장률(CAGR)로 성장하여 2033년에는 200억 달러에 달할 것으로 예측했습니다. 맞춤형 의료에 대한 대중의 관심 증가, 연구개발(R&D) 활동에 대한 투자 증가, 희귀질환에 대한 인식과 이해도 증가 등이 시장 성장의 주요 요인으로 꼽힙니다.
생물보존이란 세포, 조직, 장기, 생물체 등 생물학적 물질을 생존 가능하고 기능적인 상태로 장기간 보존하는 과정을 말합니다. 이 과정의 목적은 생물물질의 완전성, 생존능력, 기능성을 유지하여 연구, 임상응용, 산업공정 등 다양한 목적으로 보존, 수송, 활용을 가능하게 하는 것입니다. 이식, 재생의료, 의약품 개발을 위한 세포, 조직, 장기의 보존을 가능하게 하기 때문에 의료, 생명공학, 연구 등 다양한 분야에서 수많은 용도가 있습니다.
세계 시장의 주요 원동력은 개인 맞춤형 의료에 대한 대중의 관심이 증가하고 있다는 점입니다. 또한, 생명과학, 생명공학, 헬스케어 분야에서 정부, 학계, 민간 기관의 연구개발(R&D) 활동에 대한 투자 증가가 시장을 견인하고 있습니다. 또한, 희귀질환 및 유전성 질환에 대한 인식과 이해가 높아짐에 따라 환자들의 생물학적 샘플을 보존할 필요성이 증가하고 있습니다. 이러한 기술은 질병 메커니즘 연구, 진단법 개발, 표적 치료법 개발을 촉진하기 위한 시료의 수집 및 보존을 지원하여 전 세계적인 수요에 기여하고 있습니다. 또한, 개선된 동결 보호제, 자동화 시스템, 강화된 보존 프로토콜의 개발은 보존된 생물 시료의 효율성, 신뢰성, 안전성을 유지하는 데 도움이 되어 생물 보존의 능력과 응용을 확장하고 시장 전망을 더욱 밝게 하고 있습니다.
바이오뱅크 수요 증가
바이오뱅크 수요 증가는 세계 시장에 큰 영향을 미치고 있습니다. 바이오뱅크는 연구 및 진단 목적으로 세포, 조직, 혈액, DNA, 기타 생체 물질을 포함한 다양한 생물학적 샘플을 저장하는 보관소입니다. 이러한 샘플의 무결성, 생존 가능성, 기능성을 유지하고 장기 보존 및 사용 가능성을 보장하는 데 있어 이러한 기술은 중요한 역할을 합니다. 대규모 집단 기반 연구, 임상시험, 다양하고 잘 보존된 생물학적 샘플에 대한 접근을 필요로 하는 연구 프로젝트에 대한 요구가 증가함에 따라 전 세계 바이오뱅크 분야에 영향을 미치고 있습니다. 또한, 정밀의료와 개인 맞춤형 의료에 대한 관심이 높아지면서 유전체 검사, 바이오마커 탐색, 맞춤형 치료법 개발에 사용할 수 있는 종합적인 샘플 컬렉션을 제공하는 바이오뱅크의 중요성이 커지고 있습니다.
재생의료의 끊임없는 발전
재생의료의 발전은 세계 시장에 큰 영향을 미치고 있습니다. 재생의료는 세포 기반 치료법, 조직공학 및 기타 혁신적인 접근법을 사용하여 손상된 조직과 장기를 복구하거나 대체하는 것을 목표로 하기 때문에 생체 보존은 세포, 조직 및 인공 구조물의 생존력과 기능성을 유지함으로써 재생의료의 성공에 중요한 역할을 합니다. 재생의료의 성공에 중요한 역할을 하고 있습니다. 또한, 이러한 기술은 저장 및 운송 중 줄기세포의 생존력과 효능을 유지하는 데 필수적입니다. 냉동 및 유리화와 같은 동결보존 방법은 줄기세포를 향후 치료 및 연구에 사용하기 위해 줄기세포를 보존하는 데 일반적으로 사용됩니다. 줄기세포 보존 프로토콜과 동결 보호제의 발전으로 줄기세포의 생존력과 해동 후 기능성이 향상되어 시장 성장에 기여하고 있습니다.
바이오의약품 산업 확대
바이오 의약품 산업의 확대는 시장에 큰 영향을 미치는 요인입니다. 바이오 의약품 산업은 치료용 단백질, 항체, 백신, 세포 기반 치료제를 포함한 생물학적 약물의 개발 및 생산에 초점을 맞추었습니다. 생물학적 보존은 개발에서 유통까지의 라이프사이클을 통해 이러한 복잡한 생물학적 제제의 안정성, 품질 및 무결성을 보장하는 데 중요한 역할을 합니다. 생물학적 제제는 온도, 빛, 습도 등 환경 조건에 매우 민감하기 때문에 보존 및 운송 중 안정성과 품질을 유지하는 데 필수적인 기술로 그 수요가 크게 증가하고 있습니다. 냉동 보존, 동결 건조 및 기타 적절한 보존 방법을 채택함으로써 바이오 제약 기업은 제품의 보존 기간을 연장하고 환자에게 투여할 때 유효성과 안전성을 보장할 수 있습니다.
The global biopreservation market size reached USD 8.5 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 20.0 Billion by 2033, exhibiting a growth rate (CAGR) of 9.98% during 2025-2033. The growing focus on personalized medicine among the masses, the increasing investments in research and development (R&D) activities and the rising awareness and understanding of rare diseases are some of the major factors propelling the market.
Biopreservation refers to the process of preserving biological materials, such as cells, tissues, organs, or whole organisms, in a viable and functional state for extended periods. The goal of the process is to maintain the integrity, viability, and functionality of the biological material, allowing it to be stored, transported, and used for various purposes, including research, clinical applications, and industrial processes. It has numerous applications across various fields, including medicine, biotechnology, and research for enabling the storage of cells, tissues, and organs for transplantation, regenerative medicine, and drug development.
The global market is primarily driven by the growing focus on personalized medicine among the masses. Moreover, the increasing investments in research and development (R&D) activities by governments, academic institutions, and private organizations in the fields of life sciences, biotechnology, and healthcare is providing a boost to the market. Furthermore, the rising awareness and understanding of rare diseases and genetic disorders among individuals led to an increasing need to preserve biological samples from affected masses. These techniques support the collection and storage of these samples for studying disease mechanisms, developing diagnostics, and facilitating the development of targeted therapies, thereby contributing to the demand on the global level. Additionally, the development of improved cryoprotectants, automated systems, and enhanced storage protocols, are expanding the capabilities and applications of biopreservation as they help in maintaining the efficiency, reliability, and safety of preserved biological materials, further creating a positive market outlook.
Increasing Demand for Biobanking
The increasing demand for biobanking has a significant impact on the global market. Biobanks are repositories that store various biological samples, including cells, tissues, blood, DNA, and other biomaterials, for research and diagnostic purposes. These techniques play a crucial role in maintaining the integrity, viability, and functionality of these samples, ensuring their long-term storage and usability. The growing need for large-scale population-based studies, clinical trials, and research projects that require access to diverse and well-preserved biological samples is influencing the overall biobanks segment across the globe. Additionally, the increasing focus on precision medicine and personalized healthcare has amplified the importance of biobanks as they provide a comprehensive collection of samples that can be used for genomic testing, biomarker discovery, and the development of tailored treatments.
Continual Advancements in Regenerative Medicine
Advancements in regenerative medicine have a significant influence on the global market. Biopreservation plays a crucial role in the success of regenerative medicine by preserving the viability and functionality of cells, tissues, and engineered constructs since regenerative medicine aims to restore or replace damaged tissues or organs using cell-based therapies, tissue engineering, and other innovative approaches. Moreover, these techniques are essential for maintaining the viability and potency of stem cells during storage and transportation. Cryopreservation methods, such as freezing and vitrification, are commonly employed to preserve stem cells for future use in therapies or research. Advancements in stem cell preservation protocols and cryoprotectants have enhanced the viability and post-thaw functionality of stem cells, contributing to the growth of the market.
The Expansion of the Biopharmaceutical Industry
The expansion of the biopharmaceutical industry is a significant factor influencing the market. The biopharmaceutical industry focuses on the development and production of biological drugs, including therapeutic proteins, antibodies, vaccines, and cell-based therapies. Biopreservation plays a vital role in ensuring the stability, quality, and integrity of these complex biological products throughout their lifecycle, from development to distribution. Since biological drugs are highly sensitive to environmental conditions, such as temperature, light, and moisture, there has been a considerable increase in the demand for these techniques as they are essential for maintaining the stability and quality of these drugs during storage and transportation. By employing cryopreservation, lyophilization, or other appropriate preservation methods, biopharmaceutical companies can extend the shelf life of their products and ensure their efficacy and safety when administered to patients.
Biopreservation equipment dominates the market
Biopreservation equipment plays a dominant role in the market due to its essential role in preserving and storing biological materials. It refers to the specialized devices, instruments, and infrastructure used in various preservation techniques, such as cryopreservation, vitrification, lyophilization, and chemical fixation. This equipment ensures the optimal conditions for preserving the viability, integrity, and functionality of biological samples over extended periods. Additionally, biopreservation equipment manufacturers adhere to strict quality standards and regulations to ensure the reliability and safety of their products. The increasing demand for biobanking and research activities on account of advancements in genomics, personalized medicine, and drug development, is fueling the demand for these equipment.
On the other hand, biopreservation media, also known as cryopreservation media or storage media, are specifically designed to provide the optimal environment for preserving cells, tissues, and other biological samples. These media contain various components, including cryoprotectants, osmotic agents, antioxidants, and nutrients, which help protect cells from freezing or storage-related damage and support their viability and functionality upon thawing or reconstitution.
Biobank applications hold the largest share in the market
Biobanks are specialized facilities that are widely constructed to store and manage large collections of biological samples, including cells, tissues, blood, DNA, and other biomaterials, for research, clinical, or diagnostic purposes. Biobank applications heavily rely on biopreservation techniques in order to ensure the long-term preservation and usability of the stored samples. Biobank facilities often participate in collaborative research initiatives and multi-center studies. These initiatives involve sharing and exchanging samples among different biobanks to facilitate large-scale research projects. Biobanks involved in collaborative research efforts rely on effective techniques to ensure the compatibility, integrity, and viability of the samples during transportation and exchange.
On the contrary, drug discovery applications also play a significant role in positively affecting the market and driving the demand for these technologies and solutions. As drug discovery relies heavily on the use of cell lines and primary cells for screening, testing, and studying the efficacy and safety of potential drug candidates. Also, these technologies and equipment are essential for storing and maintaining the viability of cell-based assays and tissue samples used in high-throughput screening (HTS). The ability to preserve and retrieve these samples accurately and efficiently is crucial for conducting large-scale screening campaigns is accelerating the drug discovery process.
North America exhibits a clear dominance, accounting for the largest market share
The report has also provided a comprehensive analysis of all the major regional markets, which include North America, Europe, Asia Pacific, Latin America and the Middle East and Africa.
North America held the biggest market share due to the presence of well-established healthcare infrastructure, including advanced medical research institutions, pharmaceutical companies, and biotechnology firms. These organizations drive significant demand for these technologies to support their research, drug discovery, and clinical applications.
Moreover, North America has a robust network of biobanks, including government-funded initiatives, academic biorepositories, and private biobanks. These biobanks collect and store a wide range of biological samples for research and clinical applications, making them a significant consumer of these technologies. The well-developed infrastructure and standardization practices in North American biobanks contribute to the region's dominance in the market.
On the other hand, Asia Pacific is another largest region in this domain due to its large population and healthcare needs and the rapidly expanding biopharmaceutical industry. Furthermore, the concept of personalized medicine, tailoring medical treatments to individual patients based on their genetic and biological characteristics, is also gaining traction in the Asia Pacific region.
Top companies operating in the market recognize the growing demand for biobanking services. Biobanks serve as repositories for various biological samples used in research, diagnostics, and personalized medicine. The need for long-term preservation and storage of these samples drives the demand for biopreservation technologies and solutions. Moreover, numerous leading players are acknowledging the significant advancements in regenerative medicine and cell-based therapies. These therapies rely on the preservation of cells, tissues, and engineered constructs to ensure their viability and functionality. The growth in regenerative medicine and cell therapy drives the development and adoption of advanced these technologies and protocols. Furthermore, several key players operating in the market recognize the expanding biopharmaceutical industry. This is encouraging them to heavily invest in ensuring the quality and integrity of these samples, which is creating a positive market outlook.